
Lilly is contesting the first in a series of lawsuits brought by patients who say the company failed to inform …

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …

The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …

Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …
Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …